Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholera01:25

Cholera

40
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
40
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

19
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
19
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

699
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
699
Symbiosis00:58

Symbiosis

38.4K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
38.4K
Reservoir of Infection01:30

Reservoir of Infection

29
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

Soil-transmitted helminth infections among migrants and travelers: a 10-year retrospective study.

Tropical medicine and health·2026
Same author

Ten years of Plasmodium malariae infections in an International Health Reference Center in Barcelona: temporal trends and insights.

Malaria journal·2026
Same author

Systemic sclerosis and cardiovascular disease: an integrative perspective on immune-vascular mechanisms and emerging risk stratification strategies.

Rheumatology international·2026
Same author

Descriptive Analysis of Imported Toxocariasis Cases Diagnosed Between 2014 and 2024 in an International Health Unit in Barcelona, Spain.

Tropical medicine & international health : TM & IH·2026
Same author

Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study.

Journal of travel medicine·2026
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.9K

[Update Chagas disease].

Israel Molina1, Fernando Salvador1, Adrián Sánchez-Montalvá1

  • 1Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, PROSICS, Barcelona, España.

Enfermedades Infecciosas Y Microbiologia Clinica
|February 1, 2016
PubMed
Summary
This summary is machine-generated.

Chagas disease is increasingly found in non-endemic areas due to migration. Advances in diagnosis and treatment offer optimism for managing this neglected tropical disease.

Keywords:
Chagas diseaseDiagnosisDiagnósticoEnfermedad de ChagasTratamientoTreatmentTrypanosoma cruzi

More Related Videos

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.2K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.8K

Related Experiment Videos

Last Updated: Mar 26, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.9K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.2K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.8K

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Chagas disease (American trypanosomiasis) is expanding globally due to migration.
  • Non-endemic regions like North America, Europe, Asia, and Oceania now face increased patient populations.
  • Healthcare systems require updated knowledge for effective Chagas disease management.

Purpose of the Study:

  • To review recent advancements in Chagas disease diagnosis and treatment.
  • To highlight the challenges and future directions in managing Chagas disease in non-endemic settings.
  • To provide an optimistic outlook on controlling this neglected tropical disease.

Main Methods:

  • Review of recent clinical trials and therapeutic regimens.
  • Analysis of innovative diagnostic tools.
  • Synthesis of current knowledge on Chagas disease epidemiology and management.

Main Results:

  • Significant progress has been made in diagnostic accuracy and treatment efficacy.
  • New evidence from clinical trials informs patient management strategies.
  • Innovative tools and therapies are emerging for Chagas disease.

Conclusions:

  • The global spread of Chagas disease necessitates continuous professional development.
  • Advancements in diagnostics and therapeutics offer hope for improved patient outcomes.
  • Optimism is warranted for the future control and management of Chagas disease worldwide.